Discussing Rheumatology: August 2023
The IMID Forum22 Aug 2023

Discussing Rheumatology: August 2023

Join Prof Iain McInnes as he reviews two interesting papers. Our first paper today by Charles-Schoeman and colleagues compared paraoxonase activity in RA patients treated with tofacitinib, with a focus of PON1 genotypes. Furthermore, the relationship between PON1 genotypes and the risk of MACE and malignancy were also investigated. In our second paper, Peter Taylor and colleagues evaluated the results of several baricitinib RCTs and real-world evidence studies.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(423)

Discussing PsA: Difficult-to-manage PsA and molecular and clinical responses to zasocitinib

Discussing PsA: Difficult-to-manage PsA and molecular and clinical responses to zasocitinib

Join Professor Laura Coates and Professor Philip Mease as they discuss recent publications that explored treatment-refractory PsA through real-world EULAR-informed definitions and the longitudinal eff...

15 Okt 17min

Discussing PsA: Difficult-to-manage PsA and molecular/clinical responses to zasocitinib

Discussing PsA: Difficult-to-manage PsA and molecular/clinical responses to zasocitinib

Join Professor Laura Coates and Professor Philip Mease as they discuss recent publications that explored treatment-refractory PsA through real-world EULAR-informed definitions and the longitudinal eff...

15 Okt 17min

Disusisng PsA Sept - Audio only

Disusisng PsA Sept - Audio only

Join Professor Laura Coates and Professor Philip Mease as they discuss recent publications that explored treatment-refractory PsA through real-world EULAR-informed definitions and the longitudinal eff...

15 Okt 17min

Discussing RA: Impact of BMI on response to JAK inhibitors in RA

Discussing RA: Impact of BMI on response to JAK inhibitors in RA

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review paper by Bechman et al. where he highlights the i...

8 Okt 7min

Discussing axSpA: 52-week results from the Phase 3 BE MOBILE trials

Discussing axSpA: 52-week results from the Phase 3 BE MOBILE trials

Join Dr Sofia Ramiro and Dr Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered whether men and women with axSpA respond differently to bimeki...

30 Sep 20min

Author Interview: Doctor Elise van Mulligen, September 2026

Author Interview: Doctor Elise van Mulligen, September 2026

Join Professor Peter Nash from the Griffith University in Brisbane, and Doctor van Mulligen, from the Department of Rheumatology, Leiden University Medical Centre, as they discuss her recent paper ‘Lo...

3 Sep 21min

Discussing RA: Biologic effectiveness and treatment persistence in RA

Discussing RA: Biologic effectiveness and treatment persistence in RA

Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review papers by Finckh et al. and Charles‑Schoeman et a...

27 Aug 8min

Discussing PsA: Advances in Psoriatic Arthritis Management and Treatment Safety

Discussing PsA: Advances in Psoriatic Arthritis Management and Treatment Safety

Join Professor Laura Coates and Professor Philip Mease as they discuss a recent publication examining minimal clinically important improvement thresholds in PsA. This month’s conversation explores rec...

20 Aug 24min

Populärt inom Utbildning

rss-bara-en-till-om-beroende-medberoende
historiepodden-se
det-skaver
nu-blir-det-historia
allt-du-velat-veta
harrisons-dramatiska-historia
roda-vita-rosen
not-fanny-anymore
husmodern-med-amanda-schulman
rss-dr-bjorklund
rss-viktmedicinpodden
johannes-hansen-podcast
sa-in-i-sjalen
rikatillsammans-om-privatekonomi-rikedom-i-livet
i-vantan-pa-katastrofen
rss-ai-med-jonas-benjamin
rss-foraldramotet-bring-lagercrantz
kan-jag-sa-kan-du-podden
sektledare
rss-basta-livet